HalfLifeDBEvidence before certainty.

DPT evidence profile

The DPT study evaluates hallucinogen-like behavioral effects rather than a human plasma elimination series.

Category: psychedelic · Updated: August 7, 2026

Sources and model notes are maintained by . This page is educational, not clinical guidance. Corrections: admin@halflifedb.co.

Model statusNo curve publishedCurrent sources do not support one defensible human input
Evidence boundarySource note onlyNo animal, forensic, mixture, or proxy value is presented as a human half-life
Model scopeNot modeledThe profile explains what the available records can and cannot establish
References3Linked studies, labels, reviews, or identity records described below

DPT: evidence and interpretation notes

Why HalfLifeDB does not plot DPT

The DPT study evaluates hallucinogen-like behavioral effects rather than a human plasma elimination series. It supports pharmacology context, but not the numerical input a half-life curve requires.

What each source contributes

  • PubChem: DPT. This identity record confirms names and compound identity and does not supply a human half-life.
  • Hallucinogen-like effects of N,N-dipropyltryptamine (DPT). This supporting literature record adds compound-specific background and is used only within the limits of its design.
  • PMC: Hallucinogen-like effects of N,N-dipropyltryptamine (DPT). This supporting literature record adds compound-specific background and is used only within the limits of its design.

For DPT, the decision to withhold a curve turns on the limits visible in Hallucinogen-like effects of N,N-dipropyltryptamine (DPT). This supporting literature record adds compound-specific background, but it is used only within the limits of its design.

What evidence would change the page

What is missing for DPT is not another identity link. It is a human concentration-time record that names the analyte, route, formulation or preparation, study population, and fitted elimination phase. Hallucinogen-like effects of N,N-dipropyltryptamine (DPT) does not contain that complete set.

InterpretationCategory context and evidence limits

psychedelic context

Psychedelic duration is shaped by pharmacodynamics as well as pharmacokinetics, so subjective effects may not track a simple elimination curve.

  • The curve does not predict psychological effects or functional safety.
  • Metabolites and downstream receptor activity are not separately modeled.
  • Published estimates may come from small or specialized study populations.
EvidenceSource trail and model decision

Sources and evidence context

A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.

1 PubMed1 PMC0 DailyMed1 PubChem
  1. Identity record PubChem Compound Summary: DPT.
    Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
  2. Research abstract PubMed: Hallucinogen-like effects of N,N-dipropyltryptamine (DPT).
    Supporting literature record. Its role and study design should be read from the linked source before applying any numerical finding.
  3. Full-text research PMC: Hallucinogen-like effects of N,N-dipropyltryptamine (DPT).
    Supporting literature record. Its role and study design should be read from the linked source before applying any numerical finding.
BoundariesWhat this page cannot answer and where to continue

What this page does not answer

  • It does not estimate impairment, intoxication, or fitness to drive.
  • It does not predict urine, blood, saliva, or hair test results.
  • It does not model repeated exposure, tolerance, withdrawal, or interactions.
  • It does not replace clinician, pharmacist, toxicologist, or emergency guidance.

Continue with context

Read the medical disclaimer, methodology, and research standards before using the model for comparison.